In 2025, the U.S. awarded 52% fewer grants related to Alzheimer's research than in 2024, according to the National Institutes ...
The tools for catching Alzheimer’s early on just got even sharper.
The FDA cleared the PrecivityAD2 blood test to help diagnose Alzheimer's disease as part of a standard clinical workup, C2N ...
GlobalData on MSN
FDA clears C2N Diagnostics’ early Alzheimer’s assessment test
C2N’s Alzheimer’s test is the first to be FDA-cleared for use in patients as young as 40 who present with cognitive ...
Discover how people with sleep disturbance and mild cognitive impairment who took 5,000 IU of vitamin D daily performed ...
When I was diagnosed with early-onset Alzheimer's, I decided I would not let the disease slowly kill me. Instead, I would ...
The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an ...
When Congress returns from August recess, lawmakers will face a legislative agenda crowded with funding deadlines and ...
Experts have spoken about the signs and symptoms, whether there are gender differences and how people with Alzheimer’s can be ...
Treatment with new oral anticoagulants (NOAC) may help slow the cognitive decline rate of people with both Alzheimer's ...
Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside ...
A new approach to treating Alzheimer's Disease — a drug called IBC-Ab002 — is demonstrating encouraging results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results